[1]康凤尔,姚 杨,曹晓梅,等.ECMO治疗急性呼吸窘迫综合征预后危险因素的Meta分析[J].医学信息,2023,36(23):22-29.[doi:10.3969/j.issn.1006-1959.2023.23.006]
 KANG Feng-er,YAO Yang,CAO Xiao-mei,et al.Meta-analysis of Prognostic Risk Factors of ECMO in the Treatment of Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2023,36(23):22-29.[doi:10.3969/j.issn.1006-1959.2023.23.006]
点击复制

ECMO治疗急性呼吸窘迫综合征预后危险因素的Meta分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年23期
页码:
22-29
栏目:
医学数据科学
出版日期:
2023-12-01

文章信息/Info

Title:
Meta-analysis of Prognostic Risk Factors of ECMO in the Treatment of Acute Respiratory Distress Syndrome
文章编号:
1006-1959(2023)23-0022-08
作者:
康凤尔姚 杨曹晓梅
(西安医学院第一附属医院呼吸与危重症医学科,陕西 西安 710077)
Author(s):
KANG Feng-erYAO YangCAO Xiao-meiet al.
(Department of Pulmonary and Critical Care Medicine,the First Affiliated Hospital of Xi’an Medical University,Xi’an 710077,Shaanxi,China)
关键词:
体外膜肺氧合急性呼吸窘迫综合征SAPSⅡ评分APACHEⅡ评分SOFA评分
Keywords:
Extracorporeal membrane oxygenationAcute respiratory distress syndromeSAPSⅡ scoreAPACHEⅡ scoreSOFA score
分类号:
R563.8
DOI:
10.3969/j.issn.1006-1959.2023.23.006
文献标志码:
A
摘要:
目的 系统性评价体外膜肺氧合(ECMO)治疗急性呼吸窘迫综合征预后的危险因素。方法 计算机检索PubMed、EMbase、Web of Science、Cochrane和中国知网等数据库,筛选有关ECMO治疗ARDS预后的相关性研究,检索时限为建库至2022年3月,由2名研究者独立筛选文献、提取数据并评价纳入文献,根据RCT的偏移风险评估工具(NOS量表)对纳入的文献进行质量评价,采用Cochrane国际协作组织提供的RevMan5.4统计软件进行Meta分析。结果 共纳入31篇文章,包括5585例患者。Meta分析结果显示免疫功能不全(OR=2.63,95%CI:1.84~3.76,P<0.000 01)、ECMO前机械通气时间(MD=2.19,95%CI:1.48~2.90,P<0.000 01)、乳酸浓度(MD=0.82,95%CI:0.32~1.31,P=0.001)、危重症评分中SAPSⅡ评分(MD=6.36,95%CI:4.01~8.71,P<0.000 01)、APACHEⅡ评分(MD=2.99,95%CI:1.88~4.11,P<0.000 01)、SOFA评分(MD=1.28,95%CI:0.92~1.64,P<0.000 01)和ECMO上机时间(MD=1.93,95%CI:1.31~2.55,P<0.000 01)与患者死亡呈负相关。结论 免疫功能不全、ECMO前机械通气时间、乳酸浓度、SAPSⅡ评分、APACHEII评分、SOFA评分、ECMO上机时间是ARDS患者ECMO治疗预后的危险因素。
Abstract:
Objective To systematically evaluate the risk factors for the prognosis of extracorporeal membrane oxygenation in the treatment of acute respiratory distress syndrome.Methods The databases of PubMed, EMbase, Web of Science, Cochrane and CNKI were searched by computer to screen the related studies on the prognosis of ECMO in the treatment of ARDS. The retrieval time was from the establishment of the database to March 2022.Two researchers independently screened the literature, extracted the data and evaluated the included literature. The quality of the included literature was evaluated according to the bias risk assessment tool (NOS scale) of RCT, and the Revman5.4 statistical software provided by Cochrane International Collaboration was used for meta-analysis.Results A total of 31 literatures were included, including 5585 patients. The results of meta-analysis showed that immune dysfunction (OR=2.63,95%CI:1.84-3.76,P<0.000 01), mechanical ventilation time before ECMO (MD=2.19,95%CI:1.48-2.90,P<0.000 01), lactic acid concentration (MD=0.82,95%CI:0.32-1.31,P=0.001), SAPSⅡ score (MD=6.36,95%CI:4.01-8.71,P<0.000 01), APACHEⅡ score (MD=2.99,95%CI:1.88-4.11,P<0.000 01), SOFA score (MD=1.28,95%CI:0.92-1.64,P<0.000 01) and ECMO time (MD=1.93,95%CI:1.31-2.55,P<0.000 01) were negatively correlated with death.Conclusion Immune dysfunction, mechanical ventilation time before ECMO, lactic acid concentration, SAPSⅡ score, APACHEⅡ score, SOFA score and ECMO time are risk factors for the prognosis of ECMO in ARDS patients.

参考文献/References:

[1]Park PK,Napolitano LM,Bartlett RH.Extracorporeal membrane oxygenation in adult acute respiratory distress syndrome[J].Crit Care Clin,2011,27(3):627-646.[2]Rosenberg AA,Haft JW,Bartlett R,et al.Prolonged duration ECMO for ARDS: futility, native lung recovery, or transplantation?[J].ASAIO J,2013,59(6):642-650.[3]Wang J,Wang Y,Wang T,et al.Is Extracorporeal Membrane Oxygenation the Standard Care for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis[J].Heart Lung Circ,2021,30(5):631-641.[4]王立强,程周,廖小卒,等.体外膜氧合治疗成人急性呼吸窘迫综合征影响因素分析[J].中国体外循环杂志,2020,18(2):87-91.[5]Bergman ZR,Wothe JK,Alwan FS,et al.Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome[J].Surg Infect (Larchmt),2021,22(10):1086-1092.[6]Kutle?觢a M,Novokmet A,Josipovic Mraovic R,et al.Venovenous extracorporeal membrane oxygenation for ARDS:outcome analysis of a Croatian referral center for respiratory ECMO[J].Wien Klin Wochenschr,2017,129(13-14):497-502.[7]Spinelli E,Mauri T,Carlesso E,et al.Time-Course of Physiologic Variables During Extracorporeal Membrane Oxygenation and Outcome of Severe Acute Respiratory Distress Syndrome[J].ASAIO J,2020,66(6):663-670.[8]Huang L,Li T,Xu L,et al.Extracorporeal Membrane Oxygenation Outcomes in Acute Respiratory Distress Treatment: Case Study in a Chinese Referral Center[J].Med Sci Monit,2017,23:741-750.[9]Panholzer B,Meckelburg K,Huenges K,et al.Extracorporeal membrane oxygenation for acute respiratory distress syndrome in adults: an analysis of differences between survivors and non-survivors[J].Perfusion,2017,32(6):495-500.[10]Chiu LC,Lin SW,Chuang LP,et al.Mechanical power during extracorporeal membrane oxygenation and hospital mortality in patients with acute respiratory distress syndrome[J].Crit Care,2021,25(1):13.[11]St?觟hr F,Emmert MY,Lachat ML,et al.Extracorporeal membrane oxygenation for acute respiratory distress syndrome: is the configuration mode an important predictor for the outcome?[J].Interact Cardiovasc Thorac Surg,2011,12(5):676-680.[12]Martucci G,Panarello G,Occhipinti G,et al.Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality[J].J Intensive Care Med,2019,34(8):630-639.[13]Hilder M,Herbstreit F,Adamzik M,et al.Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score)[J].Crit Care,2017,21(1):301.[14]Blazoski C,Baram M,Hirose H.Outcomes of extracorporeal membrane oxygenation in acute respiratory distress syndrome due to COVID-19:The lessons learned from the first wave of COVID-19[J].J Card Surg,2021,36(7):2219-2224.[15]Schmidt M,Zogheib E,Rozé H,et al.The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome[J].Intensive Care Med,2013,39(10):1704-1713.[16]Serpa Neto A,Schmidt M,Azevedo LC,et al.Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis: Mechanical ventilation during ECMO[J].Intensive Care Med,2016,42(11):1672-1684. [17]Baek MS,Chung CR,Kim HJ,et al.Age is major factor for predicting survival in patients with acute respiratory failure on extracorporeal membrane oxygenation: a Korean multicenter study[J].J Thorac Dis,2018,10(3):1406-1417.[18]Tanaka S,De Tymowski C,Zappella N,et al.Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation[J].Sci Rep,2021,11(1):17225.[19]Saeed O,Tatooles AJ,Farooq M,et al.Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study[J].J Thorac Cardiovasc Surg,2022,163(6):2107-2116.e6.[20]Liu X,Xu Y,Zhang R,et al.Survival Predictors for Severe ARDS Patients Treated with Extracorporeal Membrane Oxygenation: A Retrospective Study in China[J].PLoS One,2016,11(6):e0158061.[21]Pham T,Combes A,Roze H,et al.Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis[J].Am J Respir Crit Care Med,2013,187(3):276-285.[22]Pappalardo F,Pieri M,Greco T,et al.Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score[J].Intensive Care Med,2013,39(2):275-281.[23]Beiderlinden M,Eikermann M,Boes T,et al.Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange[J].Intensive Care Med,2006,32(10):1627-31.[24]Chiu LC,Hu HC,Hung CY,et al.Dynamic driving pressure associated mortality in acute respiratory distress syndrome with extracorporeal membrane oxygenation[J].Ann Intensive Care,2017,7(1):12.[25]Song JH,Woo WK,Song SH,et al.Outcome of veno-venous extracorporeal membrane oxygenation use in acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass[J].J Thorac Dis,2016,8(7):1804-1813.[26]Brogan TV,Thiagarajan RR,Rycus PT,et al.Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database[J].Intensive Care Med,2009,35(12):2105-2114.[27]Wu MY,Huang CC,Wu TI,et al.Is There a Preinterventional Mechanical Ventilation Time Limit for Candidates of Adult Respiratory Extracorporeal Membrane Oxygenation[J].ASAIO J,2017,63(5):650-658.[28]Chiu LC,Chuang LP,Lin SW,et al.Comparisons of Outcomes between Patients with Direct and Indirect Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation[J].Membranes (Basel),2021,11(8):644.[29]Lee JH,Won JY,Kim JE,et al.Association between Cumulative Fluid Balance and Outcomes in Acute Respiratory Distress Syndrome Patients Treated with Extracorporeal Membrane Oxygenation[J].J Chest Surg,2021,54(1):36-44.[30]Warren A,Chiu YD,Villar SS,et al.Outcomes of the NHS England National Extracorporeal Membrane Oxygenation Service for adults with respiratory failure: a multicentre observational cohort study[J].Br J Anaesth,2020,125(3):259-266.[31]Bonizzoli M,Lazzeri C,Cianchi G,et al.Serial Lactate Measurements as a Prognostic Tool in Venovenous Extracorporeal Membrane Oxygenation Support[J].Ann Thorac Surg,2017,103(3):812-818.[32]Liu SQ,Huang YZ,Pan C,et al.Venovenous extra-corporeal membrane oxygenation for severe acute respiratory distress syndrome: a matched cohort study[J].Chin Med J (Engl),2019,132(18):2192-2198.[33]Lazzeri C,Cianchi G,Bonizzoli M,et al.Pulmonary vascular dysfunction in refractory acute respiratory distress syndrome before veno-venous extracorporeal membrane oxygenation[J].Acta Anaesthesiol Scand,2016,60(4):485-491.[34]Bojic A,Schellongowski P,Robak O,et al.Long-term Respiratory Extracorporeal Membrane Oxygenation and Prognosis: A Retrospective Analysis[J].ASAIO J,2021,67(3):345-352.[35]Schmidt M,Schellongowski P,Patroniti N,et al.Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study[J].Am J Respir Crit Care Med,2018,197(10):1297-1307.[36]Muller G,Flecher E,Lebreton G,et al.The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock[J].Intensive Care Med,2016,42(3):370-378.[37]Brower RG,Matthay MA,Morris A,et al.Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome[J].N Engl J Med,2000,342(18):1301-1308.[38]Enger TB,Philipp A,Lubnow M,et al.Long-Term Survival in Adult Patients With Severe Acute Lung Failure Receiving Veno-Venous Extracorporeal Membrane Oxygenation[J].Crit Care Med,2017,45(10):1718-1725.[39]Choi MJ,Ha SO,Kim HS,et al.The Simplified Acute Physiology Score II as a Predictor of Mortality in Patients Who Underwent Extracorporeal Membrane Oxygenation for Septic Shock[J].Ann Thorac Surg,2017,103(4):1246-1253.

相似文献/References:

[1]何广宾,左海涛,陈永青.呼吸机相关性肺炎对急性呼吸窘迫综合征患者预后的影响[J].医学信息,2022,35(11):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
 HE Guang-bin,ZUO Hai-tao,CHEN Yong-qing.Effect of Ventilator Associated Pneumonia on Prognosis of Patients with Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2022,35(23):89.[doi:10.3969/j.issn.1006-1959.2022.11.023]
[2]孙继飞,张 岚.肺表面活性物质治疗足月新生儿急性呼吸窘迫综合征疗效观察[J].医学信息,2019,32(02):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
 SUN Ji-fei,ZHANG Lan.Therapeutic Effect of Pulmonary Surfactant on Acute Respiratory Distress Syndrome in Full-term Neonates[J].Journal of Medical Information,2019,32(23):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
[3]徐雪峰.无创双水平气道正压通气在急性呼吸窘迫综合征患者中的应用效果分析[J].医学信息,2019,32(03):118.[doi:10.3969/j.issn.1006-1959.2019.03.037]
 XU Xue-feng.Analysis of Application Effect of Non-invasive Bi-level Positive Airway Pressure Ventilation in Patients with Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2019,32(23):118.[doi:10.3969/j.issn.1006-1959.2019.03.037]
[4]郑 新,张 颖.血清TNF-α、IL-6、IL-8水平对ARDS患者病情的预测价值[J].医学信息,2020,33(04):177.[doi:10.3969/j.issn.1006-1959.2020.04.060]
 ZHENG Xin,ZHANG Ying.Predictive Value of Serum TNF-α,IL-6 and IL-8 Levels in Patients with ARDS[J].Journal of Medical Information,2020,33(23):177.[doi:10.3969/j.issn.1006-1959.2020.04.060]
[5]张 曌,黄 斌.脓毒症并发ARDS的发病机制及预后评估研究进展[J].医学信息,2022,35(23):176.[doi:10.3969/j.issn.1006-1959.2022.23.039]
 ZHANG Zhao,HUANG Bin.Research Progress on Pathogenesis and Prognosis Evaluation of Sepsis Complicated with ARDS[J].Journal of Medical Information,2022,35(23):176.[doi:10.3969/j.issn.1006-1959.2022.23.039]
[6]王 凯,田国栋.连续血液净化联合血必净对ARDS患者氧化应激、APACHEⅡ评分的影响[J].医学信息,2021,34(22):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
 WANG Kai,TIAN Guo-dong.Effect of Continuous Blood Purification Combined with Xuebijing on Oxidative Stress and APACHEⅡ Score in ARDS Patients[J].Journal of Medical Information,2021,34(23):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
[7]吕 冰,田利成,何振芬.呼气末二氧化碳分压监测在急性呼吸窘迫综合征机械通气中的应用[J].医学信息,2022,35(03):115.[doi:10.3969/j.issn.1006-1959.2022.03.028]
 LYU Bing,TIAN Li-cheng,HE Zhen-fen.Application of End-tidal Carbon Dioxide Partial Pressure Monitoring inMechanical Ventilation of Acute Respiratory Distress Syndrome[J].Journal of Medical Information,2022,35(23):115.[doi:10.3969/j.issn.1006-1959.2022.03.028]
[8]刘锋锋,郑建杰.体外膜肺氧合联合主动脉内球囊反搏在高危患者经皮冠状动脉介入治疗中的应用[J].医学信息,2022,35(03):127.[doi:10.3969/j.issn.1006-1959.2022.03.032]
 LIU Feng-feng,ZHENG Jian-ji.Application of Extracorporeal Membrane Oxygenation Combined with Intra-aortic Balloon Counterpulsation in Percutaneous Coronary Intervention in High-risk Patients[J].Journal of Medical Information,2022,35(23):127.[doi:10.3969/j.issn.1006-1959.2022.03.032]
[9]姜文学,韦 巧,王 驰,等.老年ECMO患者早期急性胃肠损伤发生的影响因素分析[J].医学信息,2023,36(12):91.[doi:10.3969/j.issn.1006-1959.2023.12.017]
 JIANG Wen-xue,WEI Qiao,WANG Chi,et al.Analysis of Influencing Factors of Early Acute Gastrointestinal Injury in Elderly Patients with ECMO[J].Journal of Medical Information,2023,36(23):91.[doi:10.3969/j.issn.1006-1959.2023.12.017]

更新日期/Last Update: 1900-01-01